Myriad Genetics, Inc. · NASDAQ:MYGN
BlackRock, Inc. reported a 15.30% stake in Myriad Genetics, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Jul 17, 2025
BlackRock, Inc. reported a 15.30% stake in Myriad Genetics, Inc., 14,105,009 shares, as a passive investor on Jun 30, 2025. Filed Jul 17, 2025 (Schedule 13G/A).
- Stake
- 15.30%
- Shares
- 14,105,009
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 15.30% | 14,105,009 |
Source
Related
- Myriad Genetics, Inc.
- BlackRock, Inc.
- Myriad Genetics, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Apr 7, 2026
- Form 4 · Wheeler Benjamin Richard · Sep 22, 2026
- Form 4 · Sikri Vishal · Sep 17, 2026
- Form 4 · Fox Jennifer Lynne · Sep 8, 2026
- Schedule 13G · BlackRock Portfolio Management LLC · Sep 4, 2026
- Form 4 · Wheeler Benjamin Richard · Aug 17, 2026